Skip to content
Screener

Fulgent Genetics, Inc. FLGT Other Non-Current Assets

Other Non-Current Assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$6.38B+7.4%
Myriad Genetics logo
Myriad GeneticsMYGN
$5.6M-27.3%
Labcorp Holdings logo
Labcorp HoldingsLH
$769.3M+21.5%
Quest Diagnostics logo
Quest DiagnosticsDGX
$277M+2.2%
NeoGenomics logo
NeoGenomicsNEO
$265K+516%
Natera, Inc. logo
Natera, Inc.NTRA
$49.99M+21.6%

Other financials

Income statement

See full
Revenue$71.1M-3.2%
Gross profit$21.5M-24.2%
Operating income-$34.6M-74.9%
Net income-$24.8M-115%
EPS (diluted)-$0.80-116%

Balance sheet

See full
Cash & equivalents$23.4M-65.2%
Total debt$8.2M+40.5%
Total equity$1.0B-6.9%
Total assets$1.2B-4.1%

Cash flow

See full
Operating cash flow$7.1M+260%
CapEx$5.2M+10.3%
Free cash flow$1.9M+121%

Valuation

See full
Market cap$526.64M-16.5%
Enterprise value$511.45M-6.7%
P/S1.6×-0.4×

Profitability

See full
Gross margin38.7%-0.1pp
Operating margin-33.1%+17.4pp
Net margin-23%+43.3pp
FCF margin-36.9%

Returns & leverage

See full
Return on equity-6.8%+48.2pp
Debt / equity0.0×
Current ratio5.3×-1.0×

Where this comes from

Reported directly by Fulgent Genetics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 7:08 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-199065
Line itemMarch 31, 2026December 31, 2025
In-process research & development68,49068,490
Other intangible assets, net85,49964,791
Goodwill53,73125,080
Other long-term assets24,97622,856
Total assets$1,156,369$1,213,525
Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable$21,125$18,654

Item 1. Financial Statements.

FAQ

What is Fulgent Genetics, Inc.'s other non-current assets?
Fulgent Genetics, Inc. (FLGT) reported other non-current assets of $24.98M in Q1 2026.
How has Fulgent Genetics, Inc.'s other non-current assets changed year-over-year?
Fulgent Genetics, Inc.'s other non-current assets decreased by 23.6% year-over-year, from $32.71M to $24.98M.
What is the long-term trend for Fulgent Genetics, Inc.'s other non-current assets?
Over 5 years (2020 to 2025), Fulgent Genetics, Inc.'s other non-current assets has grown at a 40.7% compound annual growth rate (CAGR), from $4.14M to $22.86M.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.

Ask your AI about Fulgent Genetics, Inc.'s other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude